Effects of Antioxidant Dentifrice on Gingivitis
Study Details
Study Description
Brief Summary
The purpose of this study is to investigate the effect of a dentifrice containing L-ascorbic acid 2-phosphate magnesium salt on gingival inflammation, gingival bleeding and gingival redness.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 3 |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: Experimental toothpaste L-ascorbic acid 2-phosphate magnesium salt / fluoride |
Drug: Experimental toothpaste
Experimental toothpaste was containing 0.3% L-ascorbic acid 2-phosphate magnesium salt and 950 ppm fluoride. The registered participants were instructed to brush their teeth twice a day in their customary manner.
Other Names:
|
Placebo Comparator: Control toothpaste fluoride |
Drug: Control toothpaste
Control toothpaste was containing 950 ppm fluoride. The registered participants were instructed to brush their teeth twice a day in their customary manner.
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Gingival Index [3 months]
Secondary Outcome Measures
- Gingivitis Severity Inedex [3 months]
- Gingival Redness [3 months]
Gingival redness was measured as an indicator of the degree of local chromatic changes in the gingiva.
Other Outcome Measures
- salivary antioxidant status [3 months]
Salivary antioxidant status was assessed by the ferric reduction ability of plasma (FRAP).
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Age between ≥ 20 and < 65 y with at least 16 permanent teeth.
-
Gingival inflammation or mean baseline GI ≥ 0.5 without severe periodontal disease enough to require professional therapy.
-
Written informed consent to participate.
Exclusion Criteria:
-
Taking medications that could influence periodontal tissue health, such as antimicrobials and antihypertensives within 1 month before starting the trial.
-
Use of orthodontic appliances.
-
Pregnancy or planning to become pregnant during the trial period.
-
Previous participation in any other clinical trial.
-
Inability of patient to understand the study purpose and/or study protocols.
-
Judged unsuitable by investigators for other reasons.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Nihon University Hospital, School of Dentistry at Matsudo | Matsudo | Chiba | Japan | 271-8587 |
2 | Tohoku University Dental Hospital | Sendai | Miyagi | Japan | 980-8575 |
3 | Osaka University Dental Hospital | Suita | Osaka | Japan | 565-0871 |
4 | Nihon University Dental Hospital | Chiyoda-ku | Tokyo | Japan | 101-8310 |
Sponsors and Collaborators
- Lion Corporation
- Osaka University
- Tohoku University
- Nihon University
Investigators
- Principal Investigator: Shinya Murakami, Osaka University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- LionSDP-6